Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Asia Pacific

Set Alert for Asia Pacific

Hong Kong Poised To Speed Up Device Approvals

The Medical Device Control Office is to launch a trial program for expediting the approval of certain classes of medical devices.

Approvals Regulation Hong Kong

Dynamic China Moves Into The Fast Lane Of Medtech Regulatory Improvements

The Chinese medtech regulatory system was a key theme at the MedTech Summit in June, where regional specialists gave updates on registration timelines and electronic submissions, and signaled how the world’s biggest market-in-waiting is speeding up its regulatory improvements in a bid to become more open and less forbidding for overseas entrants.

China Regulation

EU To Join Countries Covered By India’s Clinical Investigation Waiver Rule

Indian regulators intend to waive their clinical investigation requirements for certain medical devices that are already approved in the EU.

Clinical Trials India

Cost Of Certification Under IVDR Is Going To Be Huge As Manufacturers Battle Hurdles

There has been no recent impact assessment as to how business will be affected by the text of the IVD Regulation that was finally adopted. Consultant Robyn Meurant explains how industry will be paying a high price, and why many IVD companies could go under.

United Kingdom Australia

Industry In Favor Of UDI In Australia But Wants Time To Deplete Inventory

The medical device industry is eager to explore regulatory proposals to introduce Unique Device Identification (UDI) in Australia. However, when it comes to implementation of a system, medtech firms claim they should be given enough time to clear non-UDI-compliant products from their inventory in distribution channels.

Asia Pacific Australia

Global Call To Rethink MDR Timing Sees Commission Dig Heels In Further

The calls for a delay in the implementation of the new EU MDR are becoming increasingly loud on the international front, with the US, for one, wanting to see a three-year postponement. Is the European Commission right to remain stubbornly attached to its deadline?

Medical Device International

Australia Clears Nexstim Neuromodulation Depression Treatment

Neuromodulation firm Nexstim has received regulatory clearance for its SmartFocus TMS system for treating major depressive disorder (MDD) in Australia.

Australia Approvals
See All